BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33475988)

  • 1. System-Wide Pollution of Biomedical Data: Consequence of the Search for Hub Genes of Hepatocellular Carcinoma Without Spatiotemporal Consideration.
    Sharma A; Colonna G
    Mol Diagn Ther; 2021 Jan; 25(1):9-27. PubMed ID: 33475988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feature selection with the Fisher score followed by the Maximal Clique Centrality algorithm can accurately identify the hub genes of hepatocellular carcinoma.
    Li C; Xu J
    Sci Rep; 2019 Nov; 9(1):17283. PubMed ID: 31754223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methods.
    Zhang L; Guo Y; Li B; Qu J; Zang C; Li F; Wang Y; Pang H; Li S; Liu Q
    Eur J Med Res; 2013 Oct; 18(1):35. PubMed ID: 24083576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a hub gene prognostic index for hepatocellular carcinoma.
    Shi Q; Meng Z; Tian XX; Wang YF; Wang WH
    Future Oncol; 2021 Jun; 17(17):2193-2208. PubMed ID: 33620260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma.
    Zhen L; Ning G; Wu L; Zheng Y; Yang F; Chen T; Xu W; Liu Y; Xie C; Peng L
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Biomarkers Related to Immune Cell Infiltration in Hepatocellular Carcinoma Using Gene Co-Expression Network.
    Zhou W; Chen Y; Luo R; Li Z; Jiang G; Ou X
    Pathol Oncol Res; 2021; 27():601693. PubMed ID: 34257558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
    Hou Y; Zhang G
    Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Hub Genes in Hepatocellular Carcinoma Related to Progression and Prognosis by Weighted Gene Co-Expression Network Analysis.
    Li J; Wang X; Yang J; Zhao S; Liu T; Wang L
    Med Sci Monit; 2020 Mar; 26():e920854. PubMed ID: 32200387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.
    Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L
    World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pipeline to create predictive functional networks: application to the tumor progression of hepatocellular carcinoma.
    Folschette M; Legagneux V; Poret A; Chebouba L; Guziolowski C; Théret N
    BMC Bioinformatics; 2020 Jan; 21(1):18. PubMed ID: 31937236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
    Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
    Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of sexual dimorphism‑linked gene expression profile in hepatocellular carcinoma.
    Wu Y; Yao N; Feng Y; Tian Z; Yang Y; Zhao Y
    Oncol Rep; 2019 Sep; 42(3):937-952. PubMed ID: 31322260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.